ERASur Colorectal Cancer Trial Reaches One-Third Patient Accrual Milestone
NCI-sponsored study evaluates whether aggressive local therapy improves survival for limited metastatic colorectal cancer The ERASur (Evaluation of Resection or Ablation for Limited Metastatic Colorectal Cancer) clinical trial has reached a major enrollment milestone, with more than one-third of its targeted patients now accrued, signaling strong momentum for this national study. ERASur (Alliance A022101) is investigating…